Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Circulatory Shock|April 1, 1994
Pseudomonas sepsis does not cause more severe cardiovascular dysfunction in patients than non-Pseudomonas sepsisG Pilz, P McGinn, P Boekstegers, et al.
Multiple Sclerosis and Related Disorders|January 8, 2021
Immune phenotyping study revealing caveats regarding a switch from fingolimod to cladribineR F Radlberger, I Sakic, T Moser, et al.
Critical Care Medicine|April 1, 1996
Early prediction of outcome in score-identified, postcardiac surgical patients at high risk for sepsis, using soluble tumor necrosis factor receptor-p55 concentrationsG Pilz, P Fraunberger, R Appel, et al.
Der Nervenarzt|September 14, 2007
[Prolonged migrainous aura and acute ischemic insult. Differential diagnosis by diffusion- and perfusion-weighted cMRI]J Kraus, S Golaszewski, G Luthringshausen, et al.
European Journal of Pharmacology|July 2, 1997
A post-receptor defect of adenylyl cyclase in severely failing myocardium from children with congenital heart diseaseC Reithmann, D Reber, R Kozlik-Feldmann, et al.
The British Journal of Radiology|August 25, 2012
Tricuspid annular plane systolic excursion assessed using MRI for semi-quantification of right ventricular ejection fractionU Speiser, M Hirschberger, G Pilz, et al.
Hamostaseologie|November 3, 2010
Relationship between thrombin generation and carotid intima-media thicknessH Bernhard, P Wipfler, B Leschnik, et al.
Wiener Klinische Wochenschrift|May 23, 1997
[Systemic inflammatory reactions to extracorporeal therapy measures (II): Cardiopulmonary bypass]R Prondzinsky, U Müller-Werdan, G Pilz, et al.
Infection|July 1, 1991
Supplemental immunoglobulin (ivIgG) treatment in 163 patients with sepsis and septic shock--an observational study as a prerequisite for placebo-controlled clinical trialsG Pilz, S Kääb, G Neeser, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 4, 2011
Molecular evidence of transient therapeutic effectiveness of natalizumab despite high-titre neutralizing antibodiesG Pilz, A Harrer, K Oppermann, et al.
Pageof 6